Patricia Cortazar, MD | Authors

St Imre Hospital

bart=k B u. 92-94


Neoadjuvant Therapy As a Platform for Drug Development: Current Controversies and Regulatory Perspectives

November 16, 2015

This commentary addresses our perspectives from a regulatory standpoint, as well as some controversies related to the use of neoadjuvant therapy as a platform for drug development.